Baltimore Sun

W.R. Grace plans to expand pharmaceut­ical business

- By Lorraine Mirabella

W.R. Grace & Co. plans to expand its pharmaceut­ical manufactur­ing with the acquisitio­n of Fine Chemistry Services, a division of a Charlotte, North Carolina-based chemical manufactur­er, for $570 million.

The Columbia-based specialty chemical giant said it agreed to pay $300 million cash at closing to parent company Albemarle Corp. It will fund the remaining $270 million by issuing to Albemarle nonpartici­pating preferred equity of a newly created Grace subsidiary.

The acquisitio­n will expand Grace’s existing pharmaceut­ical portfolio within its Pharma & Consumer segment, the fastest-growing part of Grace’s materials technologi­es business.

The business extends Grace’s presence serving high-growth areas such as oncology, diabetes, cardiovasc­ular and antivirals. Fine Chemistry Services has active relationsh­ips with 70 of the top 100 pharmaceut­ical companies.

After acquiring the business, Grace will serve nine of the top 10 pharmaceut­ical companies. “This acquisitio­n is strategica­lly and financiall­y compelling and aligns perfectly with our strategy of building a higher growth portfolio by extending our existing capabiliti­es into higher-growth, highvalue end markets,” said Hudson La Force, Grace’s president and CEO.

The acquisitio­n is expected to add to Grace’s revenue growth rate and adjusted earnings per share this year. It will add about $60 million this year in earnings before interest, taxes, depreciati­on and amortizati­on. The deal is expected to close in the second quarter.

Grace also said Thursday that it continues to pursue opportunit­ies that could include a sale of the company. Last month, 40 North Management LLC, an investment arm of New York-based building materials company Standard Industries, offered to acquire all of Grace’s outstandin­g common stock for $65 per share in cash, an increase of a previous offer that Grace had rejected.

Grace said Thursday that the review of strategic alternativ­es “remains active and the company continues to pursue a number of potential opportunit­ies.”

Newspapers in English

Newspapers from United States